Skip to content
10-Q

Quarterly Report

Myovant Sciences Ltd.

0001679082-23-000025

← back to feed
Filed
Jan 26, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2023 · Jan 20, 2023 97.24M sh
Shares Diluted Q3 2023 · Dec 31, 2022 96.86M sh
Shares Diluted Q3 2023 · Dec 31, 2022 96.16M sh
Shares Diluted Q3 2023 · Dec 31, 2021 93.47M sh
Shares Diluted Q3 2023 · Dec 31, 2021 92.51M sh
Capex Q3 2023 · Dec 31, 2022 $614K
Capex Q3 2023 · Dec 31, 2021 $723K
Operating Cash Flow Q3 2023 · Dec 31, 2022 −$169.78M
Operating Cash Flow Q3 2023 · Dec 31, 2021 −$168.47M
Cash And Equivalents Q3 2023 · Dec 31, 2022 $250.59M
Cash And Equivalents Q3 2023 · Mar 31, 2022 $406.7M
Cash And Equivalents Q3 2023 · Dec 31, 2021 $457.74M
Stockholders Equity Q3 2023 · Dec 31, 2022 −$558.14M
Stockholders Equity Q3 2023 · Sep 30, 2022 −$513.25M
Stockholders Equity Q3 2023 · Jun 30, 2022 −$483.52M
Stockholders Equity Q3 2023 · Mar 31, 2022 −$473.48M
Stockholders Equity Q3 2023 · Dec 31, 2021 −$432.28M
Stockholders Equity Q3 2023 · Sep 30, 2021 −$382.93M
Stockholders Equity Q3 2023 · Jun 30, 2021 −$399.63M
Stockholders Equity Q3 2023 · Mar 31, 2021 −$353.97M
Current Liabilities Q3 2023 · Dec 31, 2022 $245.75M
Current Liabilities Q3 2023 · Mar 31, 2022 $250.33M
Total Liabilities Q3 2023 · Dec 31, 2022 $961.66M
Total Liabilities Q3 2023 · Mar 31, 2022 $993.49M
Current Assets Q3 2023 · Dec 31, 2022 $386.59M
Current Assets Q3 2023 · Mar 31, 2022 $488.15M
Total Assets Q3 2023 · Dec 31, 2022 $403.52M
Total Assets Q3 2023 · Mar 31, 2022 $520.01M
Eps Diluted Q3 2023 · Dec 31, 2022 −$0.59
Eps Diluted Q3 2023 · Dec 31, 2022 −$1.29
Eps Diluted Q3 2023 · Dec 31, 2021 −$0.68
Eps Diluted Q3 2023 · Dec 31, 2021 −$1.59
Eps Basic Q3 2023 · Dec 31, 2022 −$0.59
Eps Basic Q3 2023 · Dec 31, 2022 −$1.29
Eps Basic Q3 2023 · Dec 31, 2021 −$0.68
Eps Basic Q3 2023 · Dec 31, 2021 −$1.59
Sga Expense Q3 2023 · Dec 31, 2022 $86.38M
Sga Expense Q3 2023 · Dec 31, 2022 $249.67M
Sga Expense Q3 2023 · Dec 31, 2021 $72.13M
Sga Expense Q3 2023 · Dec 31, 2021 $192.12M
Rd Expense Q3 2023 · Dec 31, 2022 $31.52M
Rd Expense Q3 2023 · Dec 31, 2022 $82.32M
Rd Expense Q3 2023 · Dec 31, 2021 $25.73M
Rd Expense Q3 2023 · Dec 31, 2021 $82.89M
Net Income Q3 2023 · Dec 31, 2022 −$57.63M
Net Income Q3 2023 · Dec 31, 2022 −$124.49M
Net Income Q3 2023 · Sep 30, 2022 −$45.62M
Net Income Q3 2023 · Jun 30, 2022 −$21.24M
Net Income Q3 2023 · Dec 31, 2021 −$63.45M
Net Income Q3 2023 · Dec 31, 2021 −$146.7M
Net Income Q3 2023 · Sep 30, 2021 −$21.59M
Net Income Q3 2023 · Jun 30, 2021 −$61.66M
Operating Income Q3 2023 · Dec 31, 2022 −$51.9M
Operating Income Q3 2023 · Dec 31, 2022 −$94.97M
Operating Income Q3 2023 · Dec 31, 2021 −$59.74M
Operating Income Q3 2023 · Dec 31, 2021 −$135.41M